Zydus Lifesciences confirms the dematerialization of equity shares for the quarter ended December 31, 2025. The company received certification from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), verifying that share certificates have been mutilated and canceled after due verification. The depository’s name has been substituted as the registered owner for the dematerialized shares. The securities are listed on BSE Limited and the National Stock Exchange of India Limited.
Dematerialization Confirmation
Zydus Lifesciences has announced the confirmation of dematerialization of equity shares for Q3 2026, specifically for the quarter ending on December 31, 2025. This confirmation follows the receipt of a certificate from MUFG Intime India Private Limited, the company’s Registrar and Transfer Agent (RTA).
Details of Compliance
According to the certificate, the certificates of equity shares received for dematerialization have been properly mutilated and canceled after due verification. Furthermore, the name of the respective depository has been duly substituted as the registered owner in respect of the dematerialized equity shares. This process ensures compliance with regulatory requirements for share dematerialization.
Listing Status
The company also confirms that the securities represented by the dematerialized equity shares are listed on both the BSE Limited (Bombay Stock Exchange) and the National Stock Exchange of India Limited (NSE), reinforcing their availability for trading on these platforms.
Source: BSE
